LINC00938: A Potential Drug Target and Biomarker (G400027)

Target Name: LINC00938

NCBI ID: G400027

LINC00938

Other Name(s): Long intergenic non-protein coding RNA 938 | long intergenic non-protein coding RNA 938

LINC00938: A Potential Drug Target and Biomarker

LINC00938 is a long intergenic non-protein coding RNA (lncRNA) with a length of 229 nucleotides. It is located between the genes HO-13 and HO-14 on chromosome 6 and has been predicted to encode a protein. However, recent studies have suggested that it may have other functions as well, including acting as a potential drug target and biomarker. In this article, we will explore the potential drug target and biomarker properties of LINC00938.

Potential Drug Target

The potential drug target for LINC00938 is its ability to interact with several protein-coding genes, including KLF1, IDH1, and HIF1伪. These genes are known to play important roles in various cellular processes, including cell growth, metabolism, and stress response. By interacting with these proteins, LINC00938 may be able to regulate their activity and contribute to the development of various diseases, including cancer.

In addition, LINC00938 has been shown to be highly expressed in several types of cancer, including breast, ovarian, and colorectal cancer. This increased expression may indicate that LINC00938 is a potential drug target for these cancers, and that targeting its activity may be an effective way to treat these diseases.

Biomarker

LINC00938 has also been predicted to serve as a biomarker for several diseases, including cancer. Its increased expression in cancer cells, as well as its interaction with protein-coding genes, may suggest that it plays a role in the development and progression of these diseases.

In addition, LINC00938 has been shown to be downregulated in several types of cancer, including breast, ovarian, and colorectal cancer. This downregulation may indicate that targeting its activity in these cells could be an effective way to increase the expression of cancer-related genes and enhance the therapeutic response to cancer treatments.

Conclusion

In conclusion, LINC00938 is a long intergenic non-protein coding RNA that has been predicted to encode a protein and has the potential to serve as a drug target and biomarker. Its interaction with protein-coding genes and its increased expression in cancer cells make it an attractive target for researchers to investigate further. Further studies are needed to determine the full scope of LINC00938's potential as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 938

The "LINC00938 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00938 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets